Evoke Pharma Inc (NASDAQ:EVOK)

6.56
Delayed Data
As of Apr 24
 +0.049 / +0.75%
Today’s Change
4.72
Today|||52-Week Range
10.28
+11.17%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$40.3M

Company Description

Evoke Pharma, Inc. operates as a pharmaceutical company, which focuses on the development of drugs to treat gastrointestinal, or GI, disorders and diseases. It develops EVK-001a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matt J. D'Onofrio, Cam L. Garner, Scott L. Glenn and David A. Gonyer on January 29, 2007 and is headquartered in San Diego, CA.

Contact Information

Evoke Pharma, Inc.
505 Lomas Santa Fe Drive
Solana Beach California 92075
P:(858) 345-1494
Investor Relations:

Employees

Shareholders

Individual stakeholders52.23%
Other institutional5.49%
Mutual fund holders2.35%

Top Executives

David A. GonyerPresident, Chief Executive Officer & Director
Marilyn R. CarlsonChief Medical Officer
Matthew J. D'OnofrioSecretary, Treasurer, Chief Business Officer & EVP

To view my watchlist

Not a member yet?

Sign up now for a free account